clear

Chris Sweda/Chicago Tribune/Tribune News Service via Getty Images (NEW YORK) — A U.S. Food and Drug Administration analysis did not find a clear association between the COVID-19 antiviral drug Paxlovid and illness rebound, the FDA said in a new report. Rebound rates are around the same in people who took the drug and those who didn’t, […]